| Name | Rezk Medical Supply |
|---|---|
| Organization Name | Joseph Rezk |
| Location | 112 S Main St, Butler, Pennsylvania 16001 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (724) 477-0030 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.
KUHF's Carrie Feibel, reporting as part of a partnership with Kaiser Health News, NPR and KUHF, writes: "The deal that federal regulators struck with Texas this week to expand managed care coverage for the poor allows both Gov. Rick Perry, a Republican presidential contender, and a Democratic White House to claim victory for their very different healthcare agendas."
› Verified 3 days ago
| NPI Number | 1215548276 |
| Organization Name | TRICOUNTY MEDICAL EQUIPMENT AND SUPPLY, LLC |
| Doing Business As | REZK MEDICAL SUPPLY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2901 New Butler Rd, New Castle, PA 16101 |
| Phone Number | 724-477-0030 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.
KUHF's Carrie Feibel, reporting as part of a partnership with Kaiser Health News, NPR and KUHF, writes: "The deal that federal regulators struck with Texas this week to expand managed care coverage for the poor allows both Gov. Rick Perry, a Republican presidential contender, and a Democratic White House to claim victory for their very different healthcare agendas."
› Verified 3 days ago
| NPI Number | 1326659384 |
| Organization Name | TRICOUNTY MEDICAL EQUIPMENT AND SUPPLY, LLC |
| Doing Business As | REZK MEDICAL SUPPLY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1295 Grand Blvd Ste 105, Monessen, PA 15062 |
| Phone Number | 724-477-0030 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.
KUHF's Carrie Feibel, reporting as part of a partnership with Kaiser Health News, NPR and KUHF, writes: "The deal that federal regulators struck with Texas this week to expand managed care coverage for the poor allows both Gov. Rick Perry, a Republican presidential contender, and a Democratic White House to claim victory for their very different healthcare agendas."
› Verified 3 days ago
| NPI Number | 1568073534 |
| Organization Name | TRICOUNTY MEDICAL EQUIPMENT AND SUPPLY, LLC |
| Doing Business As | REZK MEDICAL SUPPLY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 109 E Mahoning St, Punxsutawney, PA 15767 |
| Phone Number | 724-477-0030 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.
KUHF's Carrie Feibel, reporting as part of a partnership with Kaiser Health News, NPR and KUHF, writes: "The deal that federal regulators struck with Texas this week to expand managed care coverage for the poor allows both Gov. Rick Perry, a Republican presidential contender, and a Democratic White House to claim victory for their very different healthcare agendas."
› Verified 3 days ago
| NPI Number | 1891866810 |
| Organization Name | JOSEPH REZK |
| Doing Business As | REZK MEDICAL SUPPLY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 112 S Main St, Butler, PA 16001 |
| Phone Number | 724-477-0030 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.
KUHF's Carrie Feibel, reporting as part of a partnership with Kaiser Health News, NPR and KUHF, writes: "The deal that federal regulators struck with Texas this week to expand managed care coverage for the poor allows both Gov. Rick Perry, a Republican presidential contender, and a Democratic White House to claim victory for their very different healthcare agendas."
› Verified 3 days ago
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Explosive advancement in human genome sequencing opens new possibilities for identifying the genetic roots of certain diseases and finding cures. However, so many variations among individual genomes exist that identifying mutations responsible for a specific disease has in many cases proven an insurmountable challenge.
Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.
KUHF's Carrie Feibel, reporting as part of a partnership with Kaiser Health News, NPR and KUHF, writes: "The deal that federal regulators struck with Texas this week to expand managed care coverage for the poor allows both Gov. Rick Perry, a Republican presidential contender, and a Democratic White House to claim victory for their very different healthcare agendas."
› Verified 3 days ago
Bds Personal Care Products Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 224 W Diamond St, Butler, Pennsylvania 16001 Phone: (724) 285-4284 | |
Butler Eye Care Llc Type: Eyewear Supplier (Equipment, not the service) Location: 391 Evans City Rd, Butler, Pennsylvania 16001 Phone: (724) 283-8144 | |
De La Torre Orthotics & Prothetics Type: Durable Medical Equipment & Medical Supplies Supplier Location: 103 S Duffy Rd, Butler, Pennsylvania 16001 Phone: (724) 283-2000 | |
Donald A Nebel Od Type: Durable Medical Equipment & Medical Supplies Supplier Location: 261 Sunset Dr, Butler, Pennsylvania 16001 Phone: (724) 283-2500 | |
Giant Eagle Pharmacy #2415 Type: Pharmacy Location: 1521 North Main Street, Butler, Pennsylvania 16001 Phone: (724) 282-9160 |